Rocket Pharmaceuticals (RCKT) Short Interest Ratio & Short Volume → The most important AI company you've never heard of (From Manward Press) (Ad) Free RCKT Stock Alerts $23.45 -0.21 (-0.89%) (As of 09:43 AM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Rocket Pharmaceuticals Short Interest DataCurrent Short Volume9,840,000 sharesPrevious Short Volume11,000,000 sharesChange Vs. Previous Month-10.55%Dollar Volume Sold Short$211.76 millionShort Interest Ratio / Days to Cover13.5Last Record DateApril 30, 2024Outstanding Shares90,780,000 sharesPercentage of Shares Shorted10.84%Today's Trading Volume10,027 sharesAverage Trading Volume691,454 sharesToday's Volume Vs. Average1% Short Selling Rocket Pharmaceuticals ? Sign up to receive the latest short interest report for Rocket Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatRCKT Short Interest Over TimeRCKT Days to Cover Over TimeRCKT Percentage of Float Shorted Over Time Ad Monetary GoldTrump Reveals Conspiracy Behind Fed-Controlled Digital Currency.Donald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans are implemented, it could mean the end of America as we know it.This means you must act NOW before it's too late. Rocket Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20249,840,000 shares $211.76 million -10.6%N/A13.5 $21.52 4/15/202411,000,000 shares $264.11 million +4.6%N/A15.3 $24.01 3/31/202410,520,000 shares $283.41 million +2.7%N/A14.7 $26.94 3/15/202410,240,000 shares $274.53 million +2.8%N/A13.6 $26.81 2/29/20249,960,000 shares $291.83 million +8.3%N/A12 $29.30 2/15/20249,200,000 shares $280.78 million +8.9%N/A11.3 $30.52 Get the Latest News and Ratings for RCKT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Rocket Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/31/20248,450,000 shares $242.77 million +2.4%N/A10.4 $28.73 1/15/20248,250,000 shares $236.03 million -4.2%N/A9.3 $28.61 12/31/20238,610,000 shares $258.04 million -6.5%N/A9.7 $29.97 12/15/20239,210,000 shares $260.74 million +0.9%N/A10 $28.31 11/30/20239,130,000 shares $213.00 million +0.4%N/A6.7 $23.33 11/15/20239,090,000 shares $198.53 million +0.4%N/A7 $21.84 10/31/20239,050,000 shares $163.81 million +0.7%N/A7.2 $18.10 10/15/20238,990,000 shares $157.77 million -6.5%N/A7.6 $17.55 9/30/20239,610,000 shares $196.91 million +6.7%N/A8.3 $20.49 9/15/20239,010,000 shares $211.28 million +24.5%N/A8.2 $23.45 8/31/20237,240,000 shares $113.31 million -6.2%N/A12 $15.65 8/15/20237,720,000 shares $125.37 million -1.0%N/A11.9 $16.24 7/31/20237,800,000 shares $140.79 million -2.1%N/A11.6 $18.05 7/15/20237,970,000 shares $157.17 million -2.9%N/A11.6 $19.72 6/30/20238,210,000 shares $163.13 million -1.9%N/A11.8 $19.87 6/15/20238,370,000 shares $190.42 million +6.0%N/A10.9 $22.75 5/31/20237,900,000 shares $165.35 million -2.5%N/A9.7 $20.93 5/15/20238,100,000 shares $176.34 million +0.9%N/A9.8 $21.77 4/30/20238,030,000 shares $143.90 million -2.3%N/A9.6 $17.92 4/15/20238,220,000 shares $146.64 million -9.3%N/A9.7 $17.84 3/31/20239,060,000 shares $155.20 million +1.5%N/A10.5 $17.13 3/15/20238,930,000 shares $160.83 million +7.5%N/A9.5 $18.01 2/28/20238,310,000 shares $159.64 million +9.9%N/A9.2 $19.21 2/15/20237,560,000 shares $148.33 million +11.0%N/A8.6 $19.62 1/31/20236,810,000 shares $147.98 million -8.1%N/A7.5 $21.73 1/15/20237,410,000 shares $165.76 million +5.3%N/A8.1 $22.37 12/30/20227,040,000 shares $137.77 million +0.1%N/A7.7 $19.57 12/15/20227,030,000 shares $154.80 million -7.9%N/A6.8 $22.02 11/30/20227,630,000 shares $144.05 million -2.3%N/A7.6 $18.88 11/15/20227,810,000 shares $161.67 million -16.9%N/A7.8 $20.70 10/31/20229,400,000 shares $175.40 million -0.5%N/A9.7 $18.66 10/15/20229,450,000 shares $154.41 million -16.4%15.5%9.7 $16.34 9/30/202211,300,000 shares $180.35 million -3.9%18.5%11.7 $15.96 9/15/202211,760,000 shares $183.22 million +8.3%19.2%13.5 $15.58Democrats Push to Replace Dollar With Digital Coin, Control Currency. (Ad)Donald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans are implemented, it could mean the end of America as we know it.This means you must act NOW before it's too late. RCKT Short Interest - Frequently Asked Questions What is Rocket Pharmaceuticals' current short interest? Short interest is the volume of Rocket Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 9,840,000 shares of RCKT short. Learn More on Rocket Pharmaceuticals' current short interest. What is a good short interest ratio for Rocket Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RCKT shares currently have a short interest ratio of 14.0. Learn More on Rocket Pharmaceuticals's short interest ratio. Which institutional investors are shorting Rocket Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Rocket Pharmaceuticals: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is Rocket Pharmaceuticals' short interest increasing or decreasing? Rocket Pharmaceuticals saw a decrease in short interest in the month of April. As of April 30th, there was short interest totaling 9,840,000 shares, a decrease of 10.5% from the previous total of 11,000,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Rocket Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Rocket Pharmaceuticals: Zai Lab Limited (4.39%), Amneal Pharmaceuticals, Inc. (2.31%), Deciphera Pharmaceuticals, Inc. (11.65%), Arvinas, Inc. (12.66%), Geron Co. (8.82%), Vera Therapeutics, Inc. (16.61%), Amphastar Pharmaceuticals, Inc. (11.35%), Evotec SE (0.05%), Catalyst Pharmaceuticals, Inc. (7.59%), Agios Pharmaceuticals, Inc. (11.77%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short Rocket Pharmaceuticals stock? Short selling RCKT is an investing strategy that aims to generate trading profit from Rocket Pharmaceuticals as its price is falling. RCKT shares are trading up $0.28 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Rocket Pharmaceuticals? A short squeeze for Rocket Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of RCKT, which in turn drives the price of the stock up even further. How often is Rocket Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RCKT, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: Zai Lab Short Squeeze Amneal Pharmaceuticals Short Squeeze Deciphera Pharmaceuticals Short Squeeze Arvinas Short Squeeze Geron Short Squeeze Vera Therapeutics Short Squeeze Amphastar Pharmaceuticals Short Squeeze Evotec Short Squeeze Catalyst Pharmaceuticals Short Squeeze Agios Pharmaceuticals Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:RCKT) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyWATCH: The Truth About InflationBirch GoldRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldTop 5 AI Stocks to Buy for 2024Market Moving TrendsTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeDoes this make you sick?Allegiance Gold